The Australian Global Health Alliance is delighted to welcome UNSW’s School of Population Health as the newest member of the Alliance. The University of New South Wales’s School of Population Health is the oldest and largest health management program in Australia, ranked top 50 globally for public health research. The school’s work ranges from responding to […]
Global Fund signs a record-breaking $8.54 billion in grants to fight HIV, TB and malaria 12 January 2021 GENEVA – In 2020, the Global Fund signed 157 grants for a total of US$8.54 billion for lifesaving HIV, TB and malaria programs and to strengthen systems for health. This is the highest amount of grants ever signed […]
Unitaid funding sees launch of world’s first long-acting medicines centre at University of Liverpool Geneva, 12 January 2021 – Efforts to revolutionise treatments for debilitating infectious diseases have been amplified today with the launch of a new research centre at the University of Liverpool. Established as part of a US$40 million international research consortium, primarily funded by […]
Global Fund signs a record-breaking $8.54 billion in grants to fight HIV, TB and malaria 12 January 2021 GENEVA – In 2020, the Global Fund signed 157 grants for a total of US$8.54 billion for lifesaving HIV, TB and malaria programs and to strengthen systems for health. This is the highest amount of grants ever signed […]
Unitaid funding sees launch of world’s first long-acting medicines centre at University of Liverpool Geneva, 12 January 2021 – Efforts to revolutionise treatments for debilitating infectious diseases have been amplified today with the launch of a new research centre at the University of Liverpool. Established as part of a US$40 million international research consortium, primarily funded by […]
The United States has approved US$ 4 billion for Gavi, the Vaccine Alliance to ensure lower-income economies have equitable access to safe and effective COVID-19 vaccines on the same urgent timeline as wealthier countries. These funds will help end this acute phase of the pandemic. The United States also approved its Fiscal Year 2021 contribution […]
The United States has approved US$ 4 billion for Gavi, the Vaccine Alliance to ensure lower-income economies have equitable access to safe and effective COVID-19 vaccines on the same urgent timeline as wealthier countries. These funds will help end this acute phase of the pandemic. The United States also approved its Fiscal Year 2021 contribution […]
Global Fund COVID-19 Situation Report – 27 October 2020 Global cases: : 43,341,451 confirmed. Global deaths: 1,157,509 confirmed. COVID-19 has infected 43.3 million people and killed 1.1 million since the outbreak emerged last December. “We are at a critical juncture in the pandemic” said WHO Director-General, as many countries are now seeing an exponential increase in […]
Unitaid welcomes US$40 million from Norway to fight COVID-19 22 December 2020 Geneva – Unitaid is pleased to welcome a contribution of NOK 350 million (US$40 million) from Norway towards its vital work on COVID-19 treatments and tests. As a founding member of Unitaid, Norway has been a longstanding supporter of its efforts to bring forward life-saving […]
COVAX now has agreements in place to access nearly two billion doses of several promising vaccine candidates, and laid the groundwork for further doses to be secured through contributions from donors These agreements mean that all COVAX’s 190 participating and eligible economies will be able to access doses to protect vulnerable groups in the first […]
Global Fund has awarded $1 billion to support countries’ COVID-19 responses, but funding for this purpose is now fully deployed GENEVA – The Global Fund has awarded nearly US$1 billion to 106 countries to support their responses to COVID-19, but has now fully deployed all its funding for this purpose. There are significant further needs for […]
Unitaid welcomes contribution from Canada 16 December 2020 Geneva – Unitaid welcomes contribution of C$15 million (US$11.7 million) from Canada to its ongoing work on COVID-19 therapeutics and diagnostics under the global Access to Covid-19 Tools (ACT) Accelerator. The funding, which forms part of a C$255 million overall package of support to the ACT-Accelerator, has been allocated […]
December 23rd, 2020 Unitaid welcomes contribution from Canada 16 December 2020 Geneva – Unitaid welcomes contribution of C$15 million (US$11.7 million) from Canada to its ongoing work on COVID-19 therapeutics and diagnostics under the global Access to Covid-19 Tools (ACT) Accelerator. The funding, which forms part of a C$255 million overall package of support to the ACT-Accelerator, […]
COVAX now has agreements in place to access nearly two billion doses of several promising vaccine candidates, and laid the groundwork for further doses to be secured through contributions from donors These agreements mean that all COVAX’s 190 participating and eligible economies will be able to access doses to protect vulnerable groups in the first […]
